Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells
Open Access
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 134, 111114
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
This publication has 35 references indexed in Scilit:
- Chloroaluminium phthalocyanine polymeric nanoparticles as photosensitisers: Photophysical and physicochemical characterisation, release and phototoxicity in vitroEuropean Journal of Pharmaceutical Sciences, 2013
- Eicosapentaenoic acid and docosahexaenoic acid inhibit macrophage-induced gastric cancer cell migration by attenuating the expression of matrix metalloproteinase 10The Journal of Nutritional Biochemistry, 2012
- What made sesquiterpene lactones reach cancer clinical trials?Drug Discovery Today, 2010
- Nanotechnology applied to the treatment of malariaAdvanced Drug Delivery Reviews, 2010
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of ActionClinical Cancer Research, 2008
- Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia CellsPLOS ONE, 2007
- Docosahexaenoic acid in phosphatidylcholine mediates cytotoxicity more effectively than other ω-3 and ω-6 fatty acidsCancer Letters, 1998
- Nanocapsule formation by interfacial polymer deposition following solvent displacementInternational Journal of Pharmaceutics, 1989
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983